Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced it has completed its acquisition of Ambry Genetics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback